For people suffering from depression, a day without treatment can seem like a lifetime. A new study explains why the most commonly prescribed antidepressants can take as long as six weeks to have an effect. The findings could one day lead to more effective and faster acting drugs.
Researchers train brains to use different regions for same task
Practice might not always make perfect, but it’s essential for learning a sport or a musical instrument. It's also the basis of brain training, an approach that holds potential as a non-invasive therapy to overcome disabilities caused by neurological disease or trauma.
Research at the Montreal Neurological Institute and Hospital of McGill University (The Neuro) has shown just how adaptive the brain can be, knowledge that could one day be applied to recovery from conditions such as stroke.
Researchers develop method that could one day be used in brain trauma lawsuits
Lawyers representing both sides in concussion lawsuits against sports leagues may eventually have a new tool at their disposal: a diagnostic signature that uses artificial intelligence to detect brain trauma years after it has occurred.
The Tenaquip Foundation donation will allow for faster drug development, better care for ALS patients
A generous donation by The Tenaquip Foundation will improve the quality of care available to ALS patients at The Neuro, and increase the rate at which researchers can evaluate new ALS drugs.
Canadian researchers have invented an intraoperative probe that reliably detects multiple types of tumour cells
Patients with common widespread forms of cancer will enjoy longer life expectancy and reduced risk of recurrence thanks to a multimodal optical spectroscopy probe developed by Canadian researchers.
Different forms of memory exist in the same neuron and can be manipulated separately
Scientists have known for some time that a memory is stored in the brain through changes in the strength of particular synapses, the structures that pass signals between neurons. However, how the change in strength persisted remained a mystery. Solving this mystery has important implications for remedying neurological and psychological disorders.
The article below provides insights from Dr. Mark O'Malley, an ICUF Visiting Professor with McGill University's Trottier Institute for Sustainability in Engineering and Design (TISED). Dr. O'Malley (from University College Dublin) coordinated the recently released EASAC's policy-related report on "Valuing dedicated storage in electricity grids".
Neuronavigation allows more accurate catheter placements, less surgical complications
Traumatic brain injury is a life-threatening condition that requires fast and accurate intervention. A protocol for a new tool developed by Medtronic Navigation with the help of researchers at the McGill University Health Centre (MUHC) is allowing surgeons to deliver better care than ever.
Much work to be done to improve diagnosis and treatment
When NHL star player Sidney Crosby suffered a concussion during a game in May – the fourth concussion of his career – the news made nationwide headlines. A few years earlier, a concussion had kept the Pittsburgh Penguins star off the ice for ten months.
Concussions can have serious consequences, even in cases where the victim shows few symptoms immediately. Victims often shrug off a mild blow to the head, unaware that brain damage has occurred.
ALS takes away the patient’s motor functions one at a time, and the progress of finding effective drugs to counter its insidious effects has been slow. June is ALS Month, a good time to update the public on the latest developments in ALS research taking place at The Neuro.
The Montreal Neurological Institute and Hospital (The Neuro) is recognized as a leading Canadian centre for research into amyotrophic lateral sclerosis (ALS) as well as for its care of ALS patients.
The Neuro is an important centre for stroke care in Montreal
The Montreal Neurological Institute (The Neuro) is marking Stroke Month in June to increase public awareness about the dangers of this serious condition, and the importance of early intervention. A Canadian suffers a stroke every ten minutes. Each year, about 14,000 Canadians die of stroke, making stroke the third-leading cause of death in this country.
Microglia, critical to Alzheimer’s research, can now be produced artificially
The quest for better understanding of Alzheimer’s disease (AD) has a powerful new tool at its disposal — the ability to artificially generate brain cells that have been shown to play an important role in the disease function.
**This message is sent on behalf of Yves Beauchamp, Vice-Principal (Administration and Finance) and Rose Goldstein, Vice-Principal (Research and Innovation)
The Montreal Neurological Institute and Hospital (The Neuro) is home to Canada’s first multiple sclerosis (MS) clinic, and MS research and treatment has been a major focus at The Neuro for many years. The MS clinic employs a highly specialized staff who have access to the latest research data and methods of treatment. It is a clinic where innovation and progress are paramount.
Brain diseases and disorders are the leading cause of disability, directly affecting one in three Canadians as well as millions of family members, friends, colleagues and caregivers. The Government of Canada recognizes the significant impact on the health of Canadians, and supports Canadian research on the brain and related diseases and disorders